Peter Lang Selected Research

Adenoviridae Infections (Adenovirus Infections)

8/2021	Efficacy of Brincidofovir in Pediatric Stem Cell Transplant Recipients With Adenovirus Infections.
3/2015	Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT.
2/2008	Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
2/2007	Adenovirus infection after allogeneic stem cell transplantation.
7/2006	Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.
2/2005	Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Lang Research Topics

Disease

27	Neoplasms (Cancer) 10/2022 - 01/2004
22	Leukemia 06/2021 - 02/2003
20	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 02/2003
18	Infections 01/2022 - 12/2003
15	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 12/2003
9	Neuroblastoma 10/2022 - 05/2006
7	Residual Neoplasm 11/2022 - 09/2010
6	Adenoviridae Infections (Adenovirus Infections) 08/2021 - 02/2005
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2014 - 11/2004
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 12/2003
5	COVID-19 01/2022 - 11/2020
5	Viremia 08/2015 - 11/2010
5	Lymphoma (Lymphomas) 11/2014 - 11/2004
4	Disease Progression 10/2020 - 07/2009
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2018 - 04/2006
3	Virus Diseases (Viral Diseases) 01/2022 - 07/2006
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 01/2018
3	Vomiting 04/2020 - 01/2019
3	Mycoses (Diseases, Fungus) 08/2015 - 07/2012
3	Inflammation (Inflammations) 10/2014 - 03/2010
2	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2022 - 09/2020
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 10/2020
2	Acute Promyelocytic Leukemia 08/2021 - 05/2011
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021 - 10/2019
2	Hemorrhage 10/2020 - 07/2007
2	Nausea 04/2020 - 01/2019
2	Hemoglobinopathies 01/2019 - 01/2018
2	Osteonecrosis (Kienbock's Disease) 10/2018 - 08/2012
2	Cytopenia 01/2018 - 03/2005
2	Body Weight (Weight, Body) 01/2017 - 10/2012
2	Bacteremia 01/2016 - 08/2015
2	Sepsis (Septicemia) 01/2016 - 08/2015
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2014 - 07/2009
2	Autoimmune Diseases (Autoimmune Disease) 08/2012 - 04/2004
2	Pulmonary Aspergillosis 08/2012 - 01/2012
2	Ewing Sarcoma (Sarcoma, Ewing) 09/2011 - 01/2005
2	Juvenile Myelomonocytic Leukemia 09/2011 - 02/2003
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2008 - 04/2004
2	Arteriovenous Malformations (Arteriovenous Malformation) 11/2005 - 11/2005
2	Heterotaxy Syndrome 11/2005 - 11/2005
2	Lymphopenia (Lymphocytopenia) 03/2005 - 03/2004
1	Alveolar Rhabdomyosarcoma 01/2022
1	Pheochromocytoma 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022

Drug/Important Bio-Agent (IBA)

8	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2004
5	AntigensIBA 01/2021 - 04/2004
5	SteroidsIBA 01/2021 - 03/2010
4	CytokinesIBA 01/2022 - 01/2004
4	Proteins (Proteins, Gene)FDA Link 07/2012 - 05/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 10/2014
3	Peptides (Polypeptides)IBA 01/2022 - 11/2008
3	blinatumomabIBA 06/2021 - 07/2014
3	KIR ReceptorsIBA 01/2015 - 04/2004
3	LigandsIBA 01/2015 - 01/2004
2	Anaplastic Lymphoma KinaseIBA 10/2022 - 01/2018
2	dinutuximabIBA 01/2022 - 01/2021
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 01/2019
2	Arsenic Trioxide (Trisenox)FDA Link 08/2021 - 05/2011
2	AntibodiesIBA 06/2021 - 01/2013
2	Monoclonal AntibodiesIBA 04/2021 - 01/2014
2	Interleukin-2 (IL2)IBA 01/2021 - 09/2011
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 12/2019
2	fosaprepitant FDA Link 01/2020 - 01/2019
2	AntiemeticsIBA 01/2020 - 01/2019
2	Biological ProductsIBA 11/2019 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2013
2	posaconazole FDA Link 07/2017 - 10/2012
2	Immunoglobulins (Immunoglobulin)IBA 12/2014 - 07/2014
2	liposomal amphotericin B FDA Link 07/2012 - 01/2012
2	Single-Chain AntibodiesIBA 11/2008 - 07/2005
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2007 - 05/2006
1	Bispecific AntibodiesIBA 11/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022
1	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022
1	GangliosidesIBA 01/2022
1	EnzymesIBA 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2021
1	Plasminogen Activator Inhibitor 1IBA 11/2021
1	Acyclovir (Aciclovir)FDA LinkGeneric 08/2021
1	brincidofovirIBA 08/2021

Therapy/Procedure

35	Stem Cell Transplantation 01/2021 - 12/2003
33	Therapeutics 10/2022 - 12/2003
24	Hematopoietic Stem Cell Transplantation 01/2022 - 02/2007
23	Transplantation 01/2022 - 02/2003
14	Immunotherapy 11/2022 - 05/2004
9	Drug Therapy (Chemotherapy) 01/2021 - 07/2009
4	Haploidentical Transplantation 10/2014 - 09/2004
2	Homologous Transplantation 11/2022 - 04/2015
2	Aftercare (After-Treatment) 01/2016 - 11/2014
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2015 - 01/2004
2	Right Heart Bypass (Cavopulmonary Anastomosis) 11/2005 - 11/2005
1	Chemoradiotherapy 01/2022
1	Radioimmunotherapy 01/2022
1	Contraindications 08/2021